Indication
Multiple Sclerosis Exacerbations
The Multiple Sclerosis Exacerbations pipeline: 2 tracked drugs, 2 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Multiple Sclerosis Exacerbations, so this list is not complete.
2 approved / phase 4
Market size not yet sourced. How markets are sized ↗